President Trump reportedly confronted Health Secretary Robert F. Kennedy Jr. at a Virginia golf course in May, accusing him of failing to pursue research linking vaccines to autism, a push that has put the administration on a collision course with federal courts and the medical establishment.
The confrontation, first reported by the Wall Street Journal, caught Kennedy off guard. Trump accused his health secretary of having "the yips", losing his nerve, on the vaccine issue and demanded he make autism research his top priority. Multiple sources told the Journal that Trump raises the topic in nearly every conversation with Kennedy, pressing him to find scientific evidence supporting a connection between childhood vaccines and rising autism rates.
The exchange marks the sharpest known friction point between the president and his hand-picked health chief, and it came during a period when a federal judge had already blocked the administration's efforts to scale back vaccine recommendations for children.
Before the golf-course confrontation, Kennedy and his inner circle had quietly agreed to downplay vaccines as a public priority. Calley Means, Kennedy's top adviser, circulated a memo to HHS staff categorizing policy topics by political risk. Food dye removal and dietary regulations earned a "green light." Vaccines were flagged as "red light", too politically toxic to lead with.
Internal polling backed the caution. Pollsters found that vaccine skepticism and public trust in Kennedy's advice on the subject were low, though no specific survey numbers appeared in the reporting. Kennedy's team calculated that food quality and nutrition were safer ground to build public support.
Trump overrode that calculus. He reportedly believes that lowering autism rates could define his legacy and has pushed Kennedy to treat the issue as his single most important mission. The president's insistence grew more urgent after a federal judge in Boston blocked the administration's vaccine plans in March.
That pattern of a president willing to overrule cautious advisers on personnel and policy has played out across multiple agencies. The recent departure of FDA Commissioner Marty Makary amid reported White House clashes offered another example of Trump demanding results from health officials on his own timeline.
Judge Brian E. Murphy, a Biden appointee, issued a temporary order in March that stopped federal health officials from reducing the recommended number of childhood vaccines. The vaccines affected include those for flu, rotavirus, hepatitis A, hepatitis B, some forms of meningitis, and RSV.
Murphy ruled that Kennedy had likely violated federal procedures when he revamped the Advisory Committee on Immunization Practices, the expert panel that shapes national vaccine policy. Kennedy had fired all 17 members of ACIP and replaced them with a reconstituted group that included several voices skeptical of vaccines. Murphy ordered those new appointments and all decisions made by the reconstituted committee put on hold.
The lawsuit behind that ruling was filed in July 2025 by the American Academy of Pediatrics and other medical groups in federal court in Boston. It originally targeted Kennedy's decision to stop recommending COVID-19 vaccinations for most children and pregnant women. As Kennedy took additional steps, including the ACIP overhaul, the plaintiffs updated their case to challenge the broader changes.
Richard Hughes IV, an attorney representing the AAP, pointed to the practical fallout of Murphy's order:
"ACIP as currently constituted cannot meet. How can a committee meet without nearly the entirety of its membership?"
An ACIP meeting scheduled for Atlanta was postponed in the wake of Murphy's ruling. The committee that guides vaccine recommendations for millions of American children is, for now, frozen in place.
The court fight is only one front. In November, Kennedy personally directed the Centers for Disease Control and Prevention to abandon its longstanding position that vaccines do not cause autism. That directive preceded the ACIP shake-up and the legal challenge, and it signaled how far Kennedy intended to go in reshaping federal health policy around the vaccine-autism question.
Kennedy also helped push Trump to publicly recommend against women taking Tylenol during pregnancy, a move that reportedly drew pushback from White House advisers who worried the president was wading into medical territory without sufficient scientific backing. The administration has framed these efforts as part of a broader campaign against childhood chronic disease.
HHS spokesperson Emily Hilliard told the Journal that the president and his health secretary remain united:
"Secretary Kennedy and President Trump are aligned in their commitment to confronting the chronic disease epidemic affecting America's children through rigorous, gold-standard science."
White House spokesperson Kush Desai offered a more combative defense:
"America's skyrocketing autism rates have long been ignored if not mocked. The Trump administration is committed to leaving no stone unturned to finally address these concerns with Gold Standard Science."
Those statements frame the administration's vaccine push as a matter of accountability, a refusal to accept the status quo from a medical establishment that, in the White House's telling, has failed to answer parents' questions about autism. Whether the science supports that framing is the central dispute the courts are now being asked to resolve.
The golf-course confrontation was not the only sign of strain. Key White House aides conducted what the Daily Mail described as an all-encompassing review of Kennedy's department and his management of it. Reports of internal fights between HHS and the FDA contributed to the review.
Two HHS leaders were reassigned in the aftermath, though neither their names nor the specific reasons for their reassignment appeared in the reporting. Kennedy himself was eased off day-to-day operations at HHS and repositioned as more of an "ideas guy", a shift that suggests the White House wanted his vision without his hands on the levers.
The administration has been reshuffling senior personnel across multiple departments. Trump recently named housing chief Bill Pulte as acting intelligence director, replacing Tulsi Gabbard in another high-profile move that underscored the president's willingness to swap officials who aren't delivering on his priorities.
Department staffers and lobbyists told the Journal that Trump has been listening more to Dr. Mehmet Oz, the administrator of Medicare and Medicaid Services. Some believe Oz could replace Kennedy after the midterm elections. Rumors that Kennedy would quit circulated shortly after July 4, but both Kennedy and Oz denied them.
Kennedy reportedly sees himself as in it for the long haul, potentially keeping the HHS job into the next presidential administration. He denied any plans to step down, and Trump praised him publicly at the White House Correspondents' Dinner on a Friday shortly after the golf-course confrontation.
The administration launched its appeal of Judge Murphy's ruling in late April. Kennedy then petitioned the appeals court to speed up its decision, a signal that the administration views the legal timeline as an obstacle to the president's agenda.
HHS spokesman Andrew Nixon, responding to Murphy's March ruling, made the administration's posture clear:
"HHS looks forward to this judge's decision being overturned just like his other attempts to keep the Trump administration from governing."
Murphy's blocks are temporary, they remain in effect pending either a trial or a decision for summary judgment. But the practical impact is already real. ACIP cannot meet. Vaccine recommendations are frozen. And the administration's preferred advisory panel, stacked with vaccine skeptics, sits in legal limbo. Meanwhile, the Senate is racing to confirm Trump nominees before the August recess, a reminder that the president's ability to reshape health policy depends on more than executive orders, it depends on getting his people through the confirmation process and past the courts.
The open questions are substantial. What specific research has the administration identified to support a vaccine-autism link? What were the findings of the White House review of Kennedy's department? Which HHS leaders were reassigned, and why? The reporting does not answer these questions, and the administration has not volunteered the details.
Parents who have watched autism rates climb for decades deserve honest answers, not bureaucratic evasion from either side. But the answers have to come from real science and lawful process, not from a golf-course confrontation, and not from an advisory committee that a federal judge says was assembled in violation of the law. The administration's broader push to force transparency from federal agencies is a principle worth defending. It applies here, too.
If the White House wants to challenge the medical establishment on autism, it should do so with evidence strong enough to survive a courtroom, not just a putting green.
